Completed NA INTERVENTIONAL 4-arm NCT01898234

Dialysis Membranes and Hemodynamic Tolerance

Assessment of Subjective and Hemodynamic Tolerance of Different High- and Low-flux Dialysis Membranes in Patients Undergoing Chronic Intermittent Hemodialysis: a Randomized Controlled Trial

Sponsor: Ospedale Regionale di Locarno

Conditions Dialysis Membranes and Hemodynamic Tolerance

Interventions Helixone high flux Helixone low flux Revaclear Xevonta

Updated 5 times since 2017 Last updated: Jul 9, 2013 Started: Oct 31, 2012 Primary completion: Jan 31, 2013 Completion: Jan 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01898234, this NA trial focuses on Dialysis Membranes and Hemodynamic Tolerance and remains completed. Sponsored by Ospedale Regionale di Locarno, it has been updated 5 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Oct 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ospedale Regionale di Locarno

Data source: Ospedale Regionale di Locarno

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Locarno, Switzerland